Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial

L Tonneijck; MHA Muskiet; MM Smits; T Hoekstra; MHH Kramer; Jan Danser; M Diamant; JA Joles; DH van Raalte

doi:10.1111/dom.12985

Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial

L Tonneijck, MHA Muskiet, MM Smits, T Hoekstra, MHH Kramer, Jan Danser, M Diamant, JA Joles, DH van Raalte

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

47 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1669-1680
Number of pages	12
Journal	Diabetes Obesity & Metabolism
Volume	19
Issue number	12
DOIs	https://doi.org/10.1111/dom.12985
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/dom.12985

http://hdl.handle.net/1765/101285

Cite this

Tonneijck, L., Muskiet, MHA., Smits, MM., Hoekstra, T., Kramer, MHH., Danser, J., Diamant, M., Joles, JA., & van Raalte, DH. (2017). Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial. Diabetes Obesity & Metabolism, 19(12), 1669-1680. https://doi.org/10.1111/dom.12985

@article{ce8ee3510e454f1ab11f61a5050b17d6,

title = "Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial",

author = "L Tonneijck and MHA Muskiet and MM Smits and T Hoekstra and MHH Kramer and Jan Danser and M Diamant and JA Joles and {van Raalte}, DH",

year = "2017",

doi = "10.1111/dom.12985",

language = "Undefined/Unknown",

volume = "19",

pages = "1669--1680",

journal = "Diabetes Obesity & Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "12",

}

Tonneijck, L, Muskiet, MHA, Smits, MM, Hoekstra, T, Kramer, MHH, Danser, J, Diamant, M, Joles, JA & van Raalte, DH 2017, 'Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial', Diabetes Obesity & Metabolism, vol. 19, no. 12, pp. 1669-1680. https://doi.org/10.1111/dom.12985

Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial. / Tonneijck, L; Muskiet, MHA; Smits, MM et al.
In: Diabetes Obesity & Metabolism, Vol. 19, No. 12, 2017, p. 1669-1680.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial

AU - Tonneijck, L

AU - Muskiet, MHA

AU - Smits, MM

AU - Hoekstra, T

AU - Kramer, MHH

AU - Danser, Jan

AU - Diamant, M

AU - Joles, JA

AU - van Raalte, DH

PY - 2017

Y1 - 2017

U2 - 10.1111/dom.12985

DO - 10.1111/dom.12985

M3 - Article

SN - 1462-8902

VL - 19

SP - 1669

EP - 1680

JO - Diabetes Obesity & Metabolism

JF - Diabetes Obesity & Metabolism

IS - 12

ER -